Home Trending Investigator Maksimos Sarafis of Novartis in the business fraud case

Investigator Maksimos Sarafis of Novartis in the business fraud case

0
Investigator Maksimos Sarafis of Novartis in the business fraud case

Philistor was brought to the courts of Evelpidon in the morning Destebasidis to apologize for what he is credited with in the business fraud case.

Two more defendants in the case, which, according to the materials of the criminal case, concerns the activities of an organized criminal organization, will also appear before the investigating authorities today.

To her former business manager and director of communications Novartis FI. Destembazid he is given a central role in the case, because, according to the evidence he is called to refute today, for at least two years he acted as the mastermind of a group of people who promised direct loans to entrepreneurs from foreign banking institutions. The case file states that the organization involved its victims, convincing them of obtaining direct loans from banks in the United Arab Emirates, which in a number of cases was carried out through non-existent, according to the case file, Company “Zahrat Commercial Brokers OOO” in Abu Dabi which the principal defendant represented in Greece. Potential borrowers were asked to pay a number of sums for insurance, guarantees, legalization of documents, which indicated the alleged members of the organization.

According to the police authorities, the case currently concerns seven cases totaling 800,000 euros, which the organization allegedly received.

The three defendants are now being asked to plead guilty to offenses that in some cases involve the formation of a criminal organization, fraud, forgery of documents and money laundering, and four more people are wanted in the case.

The main person involved in the case, in a public statement, denies what is attributed to him and claims that the whole case was “organized against him” by the “ND semi-state” as “the result of a wretched and revanchist targeting me, since 2018” when he testified as a protected witness in a pharmaceutical industry case Novartis.

Source: APE-MEB

Author: newsroom

Source: Kathimerini

LEAVE A REPLY

Please enter your comment!
Please enter your name here